Key facts
- MAK Capital is a hedge fund based in New York, New York with 3 tracked portfolio companies.
- Notable positions include Noveome Biotherapeutics, Trailhead Biosystems, MARABio.
- MAK Capital reports $76.8M in regulatory assets under management across 2 private funds, per its SEC Form ADV (2026-03).
About MAK Capital
32402-44P
Registered with the SEC
Form ADV · 2026-03 · CRD 158132- Regulatory AUM
- $76.8M
- Private fund assets
- $2.0B
- Private funds
- 2 · 1 private equity, 1 hedge
- Staff
- 12
- Registered office
- NEW YORK, NY
- SEC status
- Approved
Reports custody of client assets.
Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as MAK CAPITAL ONE, LLC).
Free account
See the whole book
- ·Watchlist + alerts for MAK Capital's activity
Create free account
No card required
Portfolio, priced
3 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Noveome Biotherapeutics | — | $200.0M | — | |
| Trailhead Biosystems | — | $38.6M | — | |
| MARABio | — | $34.1M | — |
Frequently asked
- What companies does MAK Capital invest in?
- MAK Capital has 3 recorded portfolio companies, including Noveome Biotherapeutics, Trailhead Biosystems, MARABio.
- What is MAK Capital's AUM?
- MAK Capital manages approximately $76.8M in assets.